Abiopharma

🔍 Bay Walter D. (Executive)

Company: Arthur J. Gallagher & Co. (AJG)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Sold 12,000 shares of Common Stock at $270.081 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 71,292.09 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: H | nature_of_ownership: Gallagher 401(k) plan account | shares_owned_after: 491.13
• Holds 24,500 shares of Non-qualified Stock Option at $127.9 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2028-03-16 | shares_owned_after: 24,500.00 | Footnotes: F2
• Holds 17,630 shares of Non-qualified Stock Option at $86.17 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2027-03-12 | shares_owned_after: 17,630.00 | Footnotes: F2
• Holds 16,952 shares of Non-qualified Stock Option at $228.2 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2033-03-01 | shares_owned_after: 16,952.00 | Footnotes: F3
• Holds 11,405 shares of Non-qualified Stock Option at $158.56 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2029-03-15 | shares_owned_after: 11,405.00 | Footnotes: F2
• Holds 11,350 shares of Non-qualified Stock Option at $337.74 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2032-03-01 | shares_owned_after: 11,350.00 | Footnotes: F4, F2
• Holds 10,884 shares of Non-qualified Stock Option at $243.54 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2031-03-01 | shares_owned_after: 10,884.00 | Footnotes: F5
• Holds 9,452 shares of Non-qualified Stock Option at $177.09 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2030-03-15 | shares_owned_after: 9,452.00 | Footnotes: F6
• Holds 5,829 shares of Notional Stock Units (Derivative)
  Date: 2026-08-24 | Code: H | shares_owned_after: 5,828.55 | Footnotes: F7, F8, F8
• Holds 4,007 shares of Phantom Stock (Derivative)
  Date: 2026-08-24 | Code: H | shares_owned_after: 4,007.18 | Footnotes: F9, F10, F10

Footnotes:

• F1: The price reported is an average weighted price. The shares were sold in multiple transactions on 8/24/2026 at prices ranging from $270.01 to $270.17. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: One-third of this stock option becomes exerciseable on each of the 3rd, 4th, and 5th anniversaries of the grant date.
• F3: One-third of this stock option becomes exercisable on each of the 3rd, 4th, and 5th anniversaries of the grant date.
• F4: Closing price of Gallagher common stock on February 28, 2025.
• F5: One-third of this stock option becomes exercisable on each of the 3rd, 4th, and 5th anniversaries of the grant date.
• F6: One-third of this stock option becomes exercisable on each of the 3rd, 4th, and 5th anniversaries of the grant date.
• F7: Each notional stock unit represents a right to receive one share of Gallagher common stock.
• F8: The notional stock units become payable in July 2026 and following the reporting person's separation from service with Gallagher.
• F9: Each share of phantom stock represents a right to receive one share of Gallagher common stock.
• F10: These shares represent awards under the Age 62 Plan, a nonqualified deferred compensation plan of the Company, which have been deemed invested in Company common stock at the election of the reporting person. Participants vest in these awards in the year they attain age 62, or after a one-year period for participants who have attained age 61.